Bunion Correction Systems Global Market Report 2025

The bunion correction systems market size has grown strongly in recent years. It will grow from $0.78 billion in 2024 to $0.84 billion in 2025 at a compound annual growth rate (CAGR) of 8%. Growth during the historical period can be attributed to the increasing prevalence of hallux valgus, a rising elderly population, greater awareness of foot deformities, improved access to orthopedic care, and a growing demand for elective corrective surgeries.

The bunion correction systems market size is expected to see strong growth in the next few years. It will grow to $1.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. Growth in the forecast period can be attributed to a heightened focus on outpatient surgical settings, increased healthcare spending in emerging markets, broader access to ambulatory surgery centers, rising patient inclination toward early corrective interventions, and the expansion of orthopedic training programs for bunion treatment. Key trends expected during this period include the shift toward patient-specific surgical planning, the adoption of AI and advanced imaging for preoperative assessment, growing use of biodegradable implants, the rise of same-day discharge protocols, and increasing demand for cosmetic foot surgeries.

The rising prevalence of arthritis and rheumatoid arthritis is expected to drive the growth of the bunion correction systems market in the coming years. Arthritis refers to the inflammation and degeneration of one or more joints, while rheumatoid arthritis (RA) is a chronic autoimmune condition marked by persistent joint inflammation and progressive tissue damage. The increase in arthritis and RA cases is largely influenced by aging populations, which are more susceptible to joint deterioration and autoimmune disorders over time. Bunion correction systems offer effective surgical solutions to address deformities and reduce joint stress, thereby enhancing mobility and quality of life for patients with arthritis-related foot conditions. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2022, 17.6% of individuals aged 16 and above experienced a long-term musculoskeletal condition such as arthritis or chronic joint or back issues, an increase from 17% in 2021. Thus, the growing incidence of arthritis and rheumatoid arthritis is fueling demand for bunion correction systems.

Leading companies in the bunion correction systems market are prioritizing the development of innovative solutions such as minimally invasive bunion correction systems to offer advanced surgical options that enhance clinical outcomes while minimizing patient recovery time. Minimally invasive bunion correction systems involve specialized instruments and techniques designed to realign the big toe joint and correct deformities through small incisions, thereby reducing soft tissue damage, shortening recovery periods, and lowering the risk of postoperative complications. For example, in February 2024, Paragon 28 Inc., a U.S.-based medical device company focused on foot and ankle orthopedics, introduced the PRECISION MIS Bunion System. This next-generation system enables minimally invasive correction of bunions using a guided, joint-preserving technique that facilitates distal metatarsal osteotomy. It features an outrigger-based mechanism and specialized cannulated screws to achieve tri-planar correction, improve bone alignment and stability, and promote faster healing with reduced postoperative discomfort.

In February 2022, DePuy Synthes, a U.S.-based orthopedic solutions provider, acquired CrossRoads Extremity Systems for an undisclosed amount. This acquisition was intended to strengthen DePuy Synthes’ capabilities in elective foot and ankle procedures by incorporating CrossRoads’ minimally invasive implant systems and sustainable instrumentation services. The move addresses increasing patient demand and supports the company’s strategic expansion within the growing extremities market. CrossRoads Extremity Systems is a U.S.-based medical device company specializing in foot and ankle implants, instrumentation systems, and bunion correction systems.

Major players in the bunion correction systems market are Johnson & Johnson MedTech, Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Enovis Corporation, Ossur hf., Wright Medical Technology Inc., Orthofix Holdings Inc., Paragon 28, Acumed LLC, Treace Medical Concepts Inc., Redpoint Global Inc., Bauerfeind AG, Algeo Ltd., Medartis AG, Nextremity Solutions Inc., BioPro Inc., Extremity Medical LLC, Samson Orthotics.

North America was the largest region in the bunion correction systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bunion correction systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bunion correction systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bunion correction systems are specialized medical devices and surgical instruments used to realign the metatarsophalangeal joint, stabilize bone structures, and correct the deformity caused by hallux valgus through either minimally invasive or open surgical procedures. These systems aim to relieve pain, restore normal foot function, and prevent further complications associated with bunions after corrective surgery.

The primary types of bunion correction procedures include osteotomy, arthrodesis, lapidus, and exostectomy. Osteotomy involves surgically cutting and realigning the bones of the big toe - typically the first metatarsal - to correct bunion-related deformities and restore joint alignment. The product categories within bunion correction systems include correction systems, implants and accessories, and wearables. These are applied in either minimally invasive or traditional surgeries and are utilized across various healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics.

The bunion correction systems market research report is one of a series of new reports that provides bunion correction systems market statistics, including bunion correction systems industry global market size, regional shares, competitors with a bunion correction systems market share, detailed bunion correction systems market segments, market trends and opportunities, and any further data you may need to thrive in the bunion correction systems industry. This bunion correction systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bunion correction systems market consists of sales of bone plates, bone screws, fixation devices, surgical guides, 3D-printed patient-specific instruments, cannulated compression screws, staple fixation systems, and orthopedic power tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.